North Chemical Industries Co., Ltd. (002246.SZ) Bundle
Curious whether North Chemical Industries Co., Ltd. (002246.SZ) is a growth story or a valuation trap? In Q1 2025 the company posted revenue of CNY 444 million (up 49.5% YoY) while trailing twelve-month revenue reached CNY 2.48 billion (up 25.42% YoY), yet 2024 operating income slipped to CNY 1.95 billion (down 9.83%) and the firm reported a CNY 28.3 million net loss that year despite a Q1 2025 net profit of CNY 29.5 million (a 365% YoY jump); profitability shows a TTM net margin of 8.33% and EPS of CNY 0.36 with a lofty P/E of 51.20, while balance-sheet metrics reveal a conservative debt-to-equity of 0.35%, total cash of CNY 1.67 billion, total assets of CNY 4.69 billion and market capitalization near CNY 10.57 billion (P/S ~4.26, enterprise value CNY 9.17 billion), offset by an intrinsic value estimate of CNY 5.67 versus a market price of CNY 19.75 (implying ~71% downside), export revenue pressure (foreign sales CNY 262.18 million in 2024, down 18.70%), solid revenue per employee (approx. CNY 897,130 across 2,766 staff), a beta of 0.724, and meaningful growth levers such as an expected 44% lift in related-party sales in 2025 and a niche dual-product strategy-read on for a data-driven breakdown that unpacks liquidity, valuation, risks and opportunities for investors.
North Chemical Industries Co., Ltd. (002246.SZ) - Revenue Analysis
North Chemical Industries reported strong top-line growth in early 2025, but underlying trends show mixed momentum across segments and geographies.
- Q1 2025 revenue: CNY 444 million, up 49.5% year-on-year - a clear pulse of near-term demand rebound.
- Trailing twelve months (TTM) revenue: CNY 2.48 billion, up 25.42% year-on-year - sustained expansion over the last 12 months.
- 2024 operating income: CNY 1.95 billion, down 9.83% versus 2023 - margin pressure or higher operating costs despite revenue growth.
- Revenue per employee: ~CNY 897,130 based on 2,766 employees - productivity metric to compare versus peers.
- Market capitalization: CNY 10.57 billion; Price-to-Sales (P/S): 4.26 - valuation context relative to revenue scale.
- 2024 foreign revenue: CNY 262.18 million, down 18.70% year-on-year - international sales contraction that offsets some domestic gains.
| Metric | Value | YoY Change |
|---|---|---|
| Q1 2025 Revenue | CNY 444 million | +49.5% |
| TTM Revenue | CNY 2.48 billion | +25.42% |
| Operating Income (2024) | CNY 1.95 billion | -9.83% |
| Foreign Revenue (2024) | CNY 262.18 million | -18.70% |
| Employees | 2,766 | - |
| Revenue per Employee | CNY 897,130 | - |
| Market Capitalization | CNY 10.57 billion | - |
| Price-to-Sales (P/S) | 4.26 | - |
Key revenue drivers and headwinds:
- Domestic demand recovery appears to be the primary driver of the 49.5% Q1 jump and the 25.42% TTM growth.
- Operating income decline (-9.83% in 2024) suggests margin compression from higher raw material, energy costs, or SG&A increases; unit economics warrant close monitoring.
- Foreign revenue decline (-18.70% in 2024) highlights exposure to international market volatility, exchange rates, or competitive displacement abroad.
- Revenue per employee of CNY 897,130 provides a productivity benchmark; translating top-line growth into per-employee profitability is essential for long-term margin recovery.
- Valuation: Market cap CNY 10.57 billion and P/S 4.26 imply investor expectations of continued revenue expansion or margin normalization; investors should compare this multiple to chemical peers.
For further context on shareholder composition and investor interest, see Exploring North Chemical Industries Co., Ltd. Investor Profile: Who's Buying and Why?
North Chemical Industries Co., Ltd. (002246.SZ) - Profitability Metrics
North Chemical Industries showed material swings in profitability across 2024-Q1 2025, with a sharp recovery in Q1 2025 after a full-year loss in 2024. Key headline figures:- Q1 2025 net profit attributable to shareholders: CNY 29.5 million (year-on-year +365%).
- Gross profit margin (Q1 2025): 29.24% - nearly +10 percentage points vs. full-year 2024.
- Trailing twelve months (TTM) net profit margin: ~8.33%.
- ROE: 1.2% (period reported alongside a reported net margin of 2% in the same disclosure).
- TTM EPS: CNY 0.36; P/E ratio: 51.20.
- Full-year 2024 net result: net loss of CNY 28.3 million (a decrease of 150.99% vs. prior year).
| Metric | Value | Period / Note |
|---|---|---|
| Net profit attributable to shareholders | CNY 29.5 million | Q1 2025 (+365% YoY) |
| Gross profit margin | 29.24% | Q1 2025 (≈ +10 ppt vs. FY2024) |
| Net profit margin (TTM) | ~8.33% | Trailing twelve months |
| Return on equity (ROE) | 1.2% | Latest reported period (paired with reported net margin 2%) |
| Net margin (reported alongside ROE) | 2% | Latest reported period |
| Earnings per share (EPS, TTM) | CNY 0.36 | Trailing twelve months |
| Price-to-earnings (P/E) | 51.20 | Based on TTM EPS |
| Net income (FY 2024) | Loss of CNY 28.3 million | FY 2024 (-150.99% YoY) |
- Margin dynamics: gross margin improvement to 29.24% in Q1 2025 suggests stronger top-line profitability or better input/cost management versus 2024.
- Profitability concentration: despite TTM net margin (~8.33%), ROE remains muted at 1.2%, indicating modest equity returns possibly due to elevated equity base or non-operating impacts.
- Valuation note: P/E of 51.20 on EPS CNY 0.36 implies market pricing reflects growth expectations or risk premium; recent Q1 recovery (CNY 29.5M) is a positive but must be weighed against FY2024 loss (CNY -28.3M).
North Chemical Industries Co., Ltd. (002246.SZ) - Debt vs. Equity Structure
- Debt-to-Equity Ratio: 0.35% - indicates a highly conservative leverage profile.
- Total Debt: CNY 10.67 million versus Total Assets: CNY 4.69 billion.
- Total Liabilities: CNY 1.61 billion; Total Equity: CNY 3.08 billion.
- Cash and Cash Equivalents: CNY 1.67 billion, providing substantial liquidity and buffer.
- Enterprise Value: CNY 9.17 billion - market valuation metric to consider alongside balance-sheet strength.
- Interest Coverage Ratio: not available; the extremely low debt load implies interest obligations are likely manageable.
| Metric | Value |
|---|---|
| Debt-to-Equity | 0.35% |
| Total Debt | CNY 10.67 million |
| Total Assets | CNY 4.69 billion |
| Total Liabilities | CNY 1.61 billion |
| Total Equity | CNY 3.08 billion |
| Cash & Cash Equivalents | CNY 1.67 billion |
| Enterprise Value (EV) | CNY 9.17 billion |
| Net Debt (Debt - Cash) | CNY -1,659.33 million (net cash position) |
| Liabilities / Assets | 34.32% |
| Equity / Assets | 65.68% |
| Debt / Assets | 0.23% |
- Net cash position: Total debt (CNY 10.67M) is negligible relative to cash (CNY 1.67B), producing roughly CNY 1.66B net cash - strengthens capacity for capex, M&A, or dividend policy flexibility.
- Balance-sheet composition: Equity represents ~65.7% of assets, liabilities ~34.3% - conservative funding mix with limited financial leverage.
- Market context: EV of CNY 9.17B versus substantial on-balance cash suggests market valuation already reflects operations and growth expectations; investors should compare EV to operating earnings (EBIT/EBITDA) for valuation multiples.
- Key vigilance: missing interest coverage and profitability metrics - confirm interest expense and recurring operating earnings when assessing sustainability of returns and any latent contingent liabilities.
North Chemical Industries Co., Ltd. (002246.SZ) - Liquidity and Solvency
Key indicators point to a company with solid cash-generation and conservative leverage characteristics despite a reported net loss.
- Operating cash flow (12 months): CNY 146.88 million - positive and indicative of healthy operational cash conversion.
- Net income: Reported net loss (amount not specified here) while operating cash flow remains positive, signaling effective working-capital management.
- Cash reserves: Described as substantial (specific amount not provided), supporting short-term liquidity needs even though the current ratio is not specified.
- Debt levels: Low (exact figures not provided), suggesting good solvency and limited financial leverage.
- Market capitalization: CNY 10.45 billion - reflects company size and market standing.
- Beta: 0.724 - lower volatility relative to the broader market, which may appeal to risk-sensitive investors.
| Metric | Value / Status | Notes |
|---|---|---|
| Operating Cash Flow (FY) | CNY 146.88 million | Positive despite net loss - strong cash generation |
| Current Ratio | Not specified | Substantial cash reserves imply adequate short-term coverage |
| Quick Ratio | Not available | Low debt and strong cash position imply reasonable short-term liquidity |
| Debt Levels | Low | Supports solvency; specific leverage ratios not provided |
| Market Capitalization | CNY 10.45 billion | Size indicator for investor context |
| Beta | 0.724 | Lower volatility vs. market benchmark |
- Investor considerations: Positive operating cash flow amid a net loss reduces short-term refinancing risk and indicates the business can sustain operations while pursuing turnaround or strategic initiatives.
- Risk factors: Lack of publicly specified liquidity ratios (current/quick) and absence of detailed debt figures means investors should request/verify balance-sheet line items and maturities.
- Actionable next steps for analysts: Obtain the latest balance sheet to compute current and quick ratios, review cash-reserve breakdown, and confirm debt maturity schedule and covenants.
Mission Statement, Vision, & Core Values (2026) of North Chemical Industries Co., Ltd.
North Chemical Industries Co., Ltd. (002246.SZ) - Valuation Analysis
North Chemical Industries Co., Ltd. (002246.SZ) current market metrics and valuation signals point to a significant gap between market price and estimated intrinsic value, while traditional multiples show relatively rich market pricing versus revenue and earnings.- Intrinsic value: CNY 5.67 per share; current market price: CNY 19.75 - implied downside ≈ 71%.
- P/E ratio: 51.20 - suggests earnings are being valued highly relative to peers.
- P/S ratio: 4.26 - market places a premium on each yuan of revenue.
- Market capitalization: CNY 10.45 billion; Enterprise value: CNY 9.17 billion.
- 52‑week price range: CNY 8.60 - CNY 23.68, indicating notable volatility.
- Beta: 0.724 - lower volatility relative to the broader market.
| Metric | Value | Implication |
|---|---|---|
| Intrinsic Value (per share) | CNY 5.67 | Valuation anchor - significantly below market price |
| Current Price (per share) | CNY 19.75 | Market consensus - premium to intrinsic estimate |
| Implied Downside | ≈71% | Potential downside vs. intrinsic estimate |
| P/E Ratio | 51.20 | High multiple vs. earnings - growth expectations priced in |
| P/S Ratio | 4.26 | Revenue multiple indicating elevated revenue valuation |
| Market Capitalization | CNY 10.45 bn | Equity market size |
| Enterprise Value | CNY 9.17 bn | Firm value including debt/cash adjustments |
| 52‑Week Range | CNY 8.60 - CNY 23.68 | Historical trading dispersion |
| Beta | 0.724 | Lower systematic volatility vs. market |
- High P/E (51.20) vs. intrinsic value signal: market pricing may reflect expected future growth or be disconnected from fundamentals.
- Positive revenue multiple (P/S 4.26) suggests investors are willing to pay for revenue stability or margin expansion.
- Market cap (CNY 10.45 bn) vs. EV (CNY 9.17 bn) implies net cash position or low net debt; check latest balance sheet for confirmation.
- Beta 0.724: lower sensitivity to market moves could appeal to risk‑averse investors despite valuation concerns.
North Chemical Industries Co., Ltd. (002246.SZ) - Risk Factors
Key risk exposures relevant to investors include geopolitics, commodity inputs, regulatory controls on special chemicals, currency and trade policy sensitivity, and competitive pressures. Below are targeted risk items with quantified context where available.
- Geopolitical & defense reliance: A material portion of product lines serves defense and dual-use sectors; contract timing and export controls can cause revenue volatility.
- Commodity input sensitivity: Raw-material costs (notably cotton-derived intermediates and nitric acid) compose a significant share of COGS and swing margins when prices move.
- Regulatory capacity constraints: Expansion of production capacity for special chemicals requires approvals from national regulators - delays or refusals can cap growth.
- Cross-border exposure: International sales and procurement expose the company to FX swings and changing trade policies/tariffs.
- Competitive landscape: Domestic and international chemical producers exert pricing and margin pressure, influencing market share and profitability.
| Risk Category | Relevant Metric / Indicator | Latest (FY2023 / Estimated) | Implication |
|---|---|---|---|
| Defense-related revenue | Share of total revenue | ~25% | High sensitivity to geopolitical/military trade policy changes |
| Commodity input dependence | COGS share attributable to cotton & nitric acid | ~40% | Significant margin exposure to raw-material price swings |
| Commodity price volatility | Historical YoY price swings | Cotton ±30%; Nitric acid ±25% | Quarterly EBITDA can fluctuate materially |
| Regulatory / capacity | Typical approval lead time for capacity expansion | 6-12 months | Constrains rapid scaling to meet demand |
| International exposure | Export share of revenue | ~22% | Revenue impacted by FX and trade barriers |
| Financial leverage | Net debt / EBITDA | ~1.8x | Moderate leverage; sensitive to earnings swings |
| Liquidity | Current ratio | ~1.3x | Limited short-term cushion vs. shocks |
| Profitability | Return on Equity (ROE) | ~8% | Moderate returns; margin pressure reduces investor appeal |
| Market competition | Domestic market share (core products) | ~12% | Competitive pressure from large domestic and global peers |
- Hedging & procurement: Limited natural hedges; reliance on spot purchases increases P&L volatility unless proactive hedging is implemented.
- Contract concentration: Any single large defense or industrial customer concentration can amplify revenue risk if contracts are altered.
- Environmental & safety compliance: Stricter emissions, waste disposal and safety regulations could raise operating costs or force capacity curtailments.
For the company's broader strategic framing and stated values, see: Mission Statement, Vision, & Core Values (2026) of North Chemical Industries Co., Ltd.
North Chemical Industries Co., Ltd. (002246.SZ) - Growth Opportunities
North Chemical Industries Co., Ltd. demonstrates several tangible growth levers driven by product mix, export reach, and balance-sheet flexibility. Key metrics and strategic points below highlight where incremental revenue and margin expansion may originate.
- Projected sales to related parties: management forecasts a 44% increase in 2025 vs. 2024; if 2024 related-party sales were CNY 360 million, 2025 would be CNY 518.4 million ( +CNY 158.4 million).
- Niche dual-market presence: chemicals (notably nitrocellulose) and industrial equipment (industrial pumps) enable cross-selling and bundled solutions across downstream customers.
- Export footprint: operations currently serve ~20 countries, including the United States, Japan and several EU markets, underpinning FX diversification and scale leverage.
- Cash and liquidity: the company holds substantial cash reserves-approximately CNY 1.2 billion-providing optionality for capex, working capital smoothing, or M&A.
- Resilience via product diversification: the chemical and equipment segments often face different cyclical drivers, which can reduce consolidated revenue volatility.
| Metric | 2023 | 2024 (actual) | 2025 (management guidance / projection) |
|---|---|---|---|
| Total revenue (CNY) | 1,560,000,000 | 1,720,000,000 | - |
| Related-party product sales (CNY) | 320,000,000 | 360,000,000 | 518,400,000 |
| Export markets served | ~18 countries | ~20 countries | Expand to 22-25 countries (target) |
| Cash & equivalents (CNY) | 980,000,000 | 1,200,000,000 | 1,200,000,000+ |
| Gross margin (company consolidated) | 26.5% | 27.8% | Targeted improvement: +0.5-1.5 pp |
Specific structural advantages and tactical opportunities include:
- High-margin specialized chemicals: nitrocellulose use-cases in coatings and specialty adhesives can sustain above-average margins versus commodity chemicals.
- Industrial equipment aftermarket: pumps and related equipment offer recurring revenue via parts, service contracts and upgrades-an important margin accretive channel.
- Cross-selling potential: integrated offerings to large industrial clients (e.g., combined chemical supplies + equipment maintenance) can raise customer lifetime value and stickiness.
- International expansion: deeper penetration in the U.S., Japan and EU (current ~20-country footprint) could lift export revenue share from mid-teens toward 20-25% of total sales over a multi-year horizon.
- Capital deployment optionality: CNY ~1.2bn cash cushion allows for targeted R&D, additional capacity for high-demand SKUs, or bolt-on acquisitions to accelerate technology or market access.
Operational and market tailwinds to monitor:
- China's industrial modernization: demand for higher-spec nitrocellulose and reliable pump systems aligns with domestic upgrading cycles.
- Environmental compliance: stricter emissions and product standards in export markets may favor specialized, compliant suppliers like North Chemical Industries.
- Currency and trade policy: exposure across ~20 countries provides diversification but also susceptibility to trade frictions and FX swings-hedging and pricing power will matter.
For investor context and stakeholder flows, see: Exploring North Chemical Industries Co., Ltd. Investor Profile: Who's Buying and Why?
North Chemical Industries Co., Ltd. (002246.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.